empresstx(@Empress_Tx) 's Twitter Profile Photo

Our CEO and cofounder Jason Park will be in the Flagship Studio next Monday at discussing how to use the power of genetics to drive small molecule drug discovery with a new level of precision.

Register to attend virtually: events.flagshippioneering.com/rarecommonvirt…

Our CEO and cofounder Jason Park will be in the Flagship Studio next Monday at #FlagshipJPM discussing how to use the power of genetics to drive small molecule drug discovery with a new level of precision.

Register to attend virtually: events.flagshippioneering.com/rarecommonvirt…

#JPM24 #JPMHC24
account_circle
RoddyMedical(@RoddyMedical) 's Twitter Profile Photo

We had such a great week in San Fran, so we wanted to share a more highlights! We were honored to be invited to the Women in Healthcare night & events throughout the week, incl. meeting other guests from around the globe & exceptional leadership.

We had such a great week in San Fran, so we wanted to share a more highlights! We were honored to be invited to the Women in Healthcare night & events throughout the week, incl. meeting other guests from around the globe & exceptional leadership.

#JPMHC24 #healthcare #hospital
account_circle
MAUMITA SAHA(@MAUMITASAHA1) 's Twitter Profile Photo

Want to know where the future of is headed and how to lead the way? Sign up for Deloitte’s events concurrent to for insights into industry trends. deloi.tt/46hXES6

Want to know where the future of #LSHC is headed and how to lead the way? Sign up for Deloitte’s events concurrent to #JPMHC24 for insights into industry trends. deloi.tt/46hXES6
account_circle
Claus Henrik Johansen(@clahjoh) 's Twitter Profile Photo

Starts om Monday - what are you excited to hear more about ? Big pharma missed out on obesity - only Novo and Lilly are the lucky ones…A few is tipping the toes ,.. But in a market worth USD50-150bn - who will choose not to take that plunge ?

#JPM24 #JPMHC24 Starts om Monday - what are you excited to hear more about ? Big pharma missed out on obesity - only Novo and Lilly are the lucky ones…A few is tipping the toes ,.. But in a market worth USD50-150bn - who will choose not to take that plunge ?
account_circle
Anthos Therapeutics(@Anthos_Tx) 's Twitter Profile Photo

At Sunday's Longwood Healthcare Leaders panel discussion, our CEO will share insights about & how we're working intentionally to advance our clinical trial program to bring new Tx options to those w/ the greatest unmet need.

At Sunday's @LongwoodLeaders panel discussion, our CEO will share insights about #AnthosTx & how we're working intentionally to advance our clinical trial program to bring new Tx options to those w/ the greatest unmet need. #LongwoodLeaders #JPM24 #JPMHC24 #JPMWeek #BioTechMonth
account_circle
RoddyMedical(@RoddyMedical) 's Twitter Profile Photo

We are thrilled to be attending the prestigious 42nd Annual J.P.Morgan Healthcare Conference in San Francisco! We're honored to be among brilliant minds and industry leadership.

J.P. Morgan

We are thrilled to be attending the prestigious 42nd Annual J.P.Morgan Healthcare Conference in San Francisco! We're honored to be among brilliant minds and industry leadership. 

#JPMHC24 #innovation #healthcare #hospital @jpmorgan #investors #startup
account_circle
Marinomed Biotech AG(@Marinomed_AG) 's Twitter Profile Photo

📢 Meet us at the 42nd Annual J.P. Morgan Healthcare Conference, taking place January 8-11, 2024, in San Francisco, CA 🌉 and learn more about our portfolio and investments opportunities!

➡ Details: jpmorgan.com/about-us/event…
➡ Contact: [email protected]

📢 Meet us at the 42nd Annual @jpmorgan Healthcare Conference, taking place January 8-11, 2024, in San Francisco, CA 🌉 and learn more about our portfolio and investments opportunities! 

➡ Details: jpmorgan.com/about-us/event…
➡ Contact: ir@marinomed.com

#oceanofideas #JPMHC24
account_circle
EyePoint Pharmaceuticals(@EyePointPharma) 's Twitter Profile Photo

Our $EYPT team had a great time at ! We helped keep attendees dry during a rainy week in with our umbrellas. ☂️ Thank you J.P. Morgan for hosting another great event!

account_circle
sionna_tx(@sionna_tx) 's Twitter Profile Photo

We had highly productive meetings with global industry leaders and provided updates on our development program at the 42nd Annual J.P. Morgan Healthcare Conference. Access our presentation here: sionnatx.com/news-publicati…

We had highly productive meetings with global industry leaders and provided updates on our #CF development program at the 42nd Annual @jpmorgan Healthcare Conference. Access our #JPMHC24 presentation here: sionnatx.com/news-publicati… #JPM2024
account_circle
Lakshman Pernenkil(@lpernenkil) 's Twitter Profile Photo

Want to know where the future of is headed and how to lead the way? Sign up for Deloitte’s events concurrent to for insights into industry trends. deloi.tt/3uwHTK5

Want to know where the future of #LSHC is headed and how to lead the way? Sign up for Deloitte’s events concurrent to #JPMHC24 for insights into industry trends. deloi.tt/3uwHTK5
account_circle
ReSurge International(@ReSurge) 's Twitter Profile Photo

about last night ✨

We were proud to represent ReSurge at , the 42nd Annual Healthcare Conference by J.P Morgan, bringing together more than 8,000 investors, industry professionals, senior government officials, and 550 global healthcare companies 🙌

about last night ✨

We were proud to represent ReSurge at #JPMHC24, the 42nd Annual Healthcare Conference by J.P Morgan, bringing together more than 8,000 investors, industry professionals, senior government officials, and 550 global healthcare companies 🙌
account_circle
Regulus Therapeutics(@RegulusTx) 's Twitter Profile Photo

We’ll be in San Francsico for J.P. Morgan in January and are excited to meet and catch up with investors, partners, and friends. If you’d like to connect with a member of our team and learn more about our work in orphan kidney disease, please reach out!

We’ll be in San Francsico for J.P. Morgan in January and are excited to meet and catch up with investors, partners, and friends. If you’d like to connect with a member of our team and learn more about our work in orphan kidney disease, please reach out!

#ADPKD #JPMHC24
account_circle
ICR Consilium(@ICRConsilium) 's Twitter Profile Photo

We asked our colleagues at ICR Healthcare what they’re looking forward to at the J.P. Morgan Healthcare Conference next week. Here’s what they said: consilium-comms.com/news-insights/……

account_circle
Adaptimmune(@Adaptimmune) 's Twitter Profile Photo

$ADAP CEO Adrian Rawcliffe spoke today at about the company’s sarcoma franchise and work from discovery to delivery of cell therapies with the potential to redefine the treatment of solid tumors.

$ADAP CEO Adrian Rawcliffe spoke today at #JPMHC24 about the company’s sarcoma franchise and work from discovery to delivery of cell therapies with the potential to redefine the treatment of solid tumors. #celltherapy #oncology #biotechnology
account_circle
Scancell(@scancellpharma) 's Twitter Profile Photo

Our CFO Sath Nirmalananthan will be attending the @JPMorgan Healthcare Conference 2024 taking place in San Francisco, CA from 8-11 Jan.

Email [email protected] to arrange a meeting.

Our CFO Sath Nirmalananthan will be attending the @JPMorgan Healthcare Conference 2024 taking place in San Francisco, CA from 8-11 Jan.

Email sathnirmalananthan@scancell.co.uk to arrange a meeting.

#JPMHC24 #immunooncology #cancer
account_circle
Crescendo Biologics(@HUMABODY) 's Twitter Profile Photo

Our CEO Theo Harold, CDO Dr Philip Bland-Ward, CMO Dr Kenji Hashimoto, and VP, Translational Biology Dr Andrew Pierce will be attending the @JPMorgan Healthcare Conference 2024 taking place in SF, CA from 8-11 Jan.

We look forward to insightful discussions.

Our CEO Theo Harold, CDO Dr Philip Bland-Ward, CMO Dr Kenji Hashimoto, and VP, Translational Biology Dr Andrew Pierce will be attending the @JPMorgan Healthcare Conference 2024 taking place in SF, CA from 8-11 Jan.

We look forward to insightful discussions.

#JPMHC24
account_circle
Adaptimmune(@Adaptimmune) 's Twitter Profile Photo

$ADAP ICYMI – replay (bit.ly/3NWDyGI) of our presentation at – where we outlined our near- and long-term value proposition with our wholly owned cell therapy pipeline. Email [email protected] to schedule time with management.

$ADAP ICYMI – replay (bit.ly/3NWDyGI) of our presentation at #JPMHC24 – where we outlined our near- and long-term value proposition with our wholly owned cell therapy pipeline. Email investor.relations@adaptimmune.com to schedule time with management.
account_circle